Compare Stocks: MBOT, OFIX, RCEL, and TMCI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MBOT Microbot Medical	$1.45	$1.66	$1.42 ▼ $3.75	$97.39M	1.03	553,632 shs	404,506 shs
OFIX Orthofix Medical	$9.11 +2.0%	$10.55	$8.61 ▼ $16.99	$363.75M	0.64	293,228 shs	324,714 shs
RCEL Avita Medical	$10.19 +3.1%	$7.37	$3.22 ▼ $11.39	$304.07M	2.02	348,629 shs	333,387 shs
TMCI Treace Medical Concepts	$4.63 +2.7%	$4.49	$1.17 ▼ $7.61	$293.31M	1.4	246,953 shs	230,155 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MBOT Microbot Medical	0.00%	+0.69%	-6.45%	-20.33%	-64.20%
OFIX Orthofix Medical	+2.02%	-1.94%	-11.90%	-3.19%	-38.90%
RCEL Avita Medical	+3.14%	-9.02%	+29.81%	+159.95%	+123.46%
TMCI Treace Medical Concepts	+2.66%	-3.74%	-3.34%	+12.38%	-35.87%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MBOT Microbot Medical	$1.45	$1.66	$1.42 ▼ $3.75	$97.39M	1.03	553,632 shs	404,506 shs
OFIX Orthofix Medical	$9.11 +2.0%	$10.55	$8.61 ▼ $16.99	$363.75M	0.64	293,228 shs	324,714 shs
RCEL Avita Medical	$10.19 +3.1%	$7.37	$3.22 ▼ $11.39	$304.07M	2.02	348,629 shs	333,387 shs
TMCI Treace Medical Concepts	$4.63 +2.7%	$4.49	$1.17 ▼ $7.61	$293.31M	1.4	246,953 shs	230,155 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MBOT Microbot Medical	0.00%	+0.69%	-6.45%	-20.33%	-64.20%
OFIX Orthofix Medical	+2.02%	-1.94%	-11.90%	-3.19%	-38.90%
RCEL Avita Medical	+3.14%	-9.02%	+29.81%	+159.95%	+123.46%
TMCI Treace Medical Concepts	+2.66%	-3.74%	-3.34%	+12.38%	-35.87%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MBOT Microbot Medical	2.40	Hold	$6.38	339.66% Upside
OFIX Orthofix Medical	2.40	Hold	$14.75	61.91% Upside
RCEL Avita Medical	2.57	Moderate Buy	$11.40	11.87% Upside
TMCI Treace Medical Concepts	1.86	Reduce	$5.17	11.66% Upside

Current Analyst Ratings Breakdown

Latest MBOT, OFIX, RCEL, and TMCI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/11/2026	OFIX Orthofix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/11/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$4.00
8/31/2026	TMCI Treace Medical Concepts	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/28/2026	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$8.00 ➝ $12.00
8/26/2026	OFIX Orthofix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/20/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/19/2026	RCEL Avita Medical	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$12.00 ➝ $14.00
8/19/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/19/2026	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $11.00
8/14/2026	TMCI Treace Medical Concepts	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.00 ➝ $4.00

(Data available from 9/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$1.15 per share	N/A
OFIX Orthofix Medical	$833.19M	0.45	N/A	N/A	$11.30 per share	0.81
RCEL Avita Medical	$71.61M	4.38	N/A	N/A	($0.55) per share	-18.53
TMCI Treace Medical Concepts	$205.31M	1.47	N/A	N/A	$1.37 per share	3.38

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MBOT Microbot Medical	-$13.14M	-$0.24	N/A	N/A	N/A	N/A	-21.87%	-20.76%	11/11/2026 (Estimated)
OFIX Orthofix Medical	-$92.19M	-$1.54	N/A	N/A	N/A	-7.41%	-14.05%	-7.17%	11/3/2026 (Estimated)
RCEL Avita Medical	-$48.59M	-$1.44	N/A	N/A	N/A	-56.96%	N/A	-78.53%	11/5/2026 (Estimated)
TMCI Treace Medical Concepts	-$59M	-$0.93	N/A	N/A	N/A	-28.99%	-71.37%	-30.49%	11/5/2026 (Estimated)

Latest MBOT, OFIX, RCEL, and TMCI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2026	Q2 2026	MBOT Microbot Medical	-$0.0767	-$0.08	-$0.0033	-$0.08	$0.13 million	$0.24 million
8/7/2026	Q2 2026	TMCI Treace Medical Concepts	-$0.2980	-$0.24	+$0.0580	-$0.24	$44.02 million	$45.38 million
8/6/2026	Q2 2026	RCEL Avita Medical	-$0.2928	-$0.25	+$0.0428	-$5.00	$20.25 million	$21.70 million
8/5/2026	Q2 2026	OFIX Orthofix Medical	-$0.4099	-$0.39	+$0.0199	-$0.39	$209.28 million	$210.93 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A
OFIX Orthofix Medical	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MBOT Microbot Medical	N/A	18.56	17.82
OFIX Orthofix Medical	0.55	2.84	1.67
RCEL Avita Medical	N/A	0.41	0.34
TMCI Treace Medical Concepts	0.83	2.90	1.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MBOT Microbot Medical	16.30%
OFIX Orthofix Medical	89.76%
RCEL Avita Medical	27.66%
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
MBOT Microbot Medical	4.74%
OFIX Orthofix Medical	2.70%
RCEL Avita Medical	2.24%
TMCI Treace Medical Concepts	23.42%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MBOT Microbot Medical	20	67.17 million	63.98 million	Optionable
OFIX Orthofix Medical	1,605	40.73 million	39.63 million	Optionable
RCEL Avita Medical	226	30.78 million	30.09 million	Optionable
TMCI Treace Medical Concepts	450	65.04 million	49.80 million	Optionable

MBOT, OFIX, RCEL, and TMCI Headlines

Recent News About These Companies

NexGel (NASDAQ:NXGL) vs. Treace Medical Concepts (NASDAQ:TMCI) Head-To-Head Survey

September 12 at 3:47 AM | americanbankingnews.com

BlackRock Inc. Takes Position in Treace Medical Concepts, Inc. $TMCI

September 6, 2026 | marketbeat.com

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Reduce" by Analysts

September 5, 2026 | marketbeat.com

Bank of America Corp DE Has $4.31 Million Stock Holdings in Treace Medical Concepts, Inc. $TMCI

August 29, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 5,000 Shares

August 25, 2026 | insidertrades.com

John Treace Acquires 5,000 Shares of Treace Medical Concepts (NASDAQ:TMCI) Stock

August 24, 2026 | marketbeat.com

Insider Buying: Treace Medical Concepts (NASDAQ:TMCI) CEO Acquires 11,000 Shares

August 24, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 39,944 Shares of Stock

August 24, 2026 | marketbeat.com

Weber Capital Management LLC ADV Takes $2.35 Billion Position in Treace Medical Concepts, Inc. $TMCI

August 24, 2026 | marketbeat.com

Treace Medical Concepts Earnings Call Signals Cautious Rebound

August 18, 2026 | tipranks.com

522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC

August 17, 2026 | marketbeat.com

Treace Medical (TMCI) Q2 2026 Earnings Call Transcript

August 14, 2026 | finance.yahoo.com

Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary

August 8, 2026 | finance.yahoo.com

Treace Medical Concepts: Q2 Earnings Snapshot

August 7, 2026 | seattlepi.comS

Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2026 | zacks.com

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

August 7, 2026 | globenewswire.com

Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

July 24, 2026 | prnewswire.com

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

July 24, 2026 | globenewswire.com

Why Treace Medical Concepts, Inc.’s (TMCI) Stock Is Down 5.42%

July 23, 2026 | aaii.comA

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)

July 13, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT, OFIX, RCEL, and TMCI Company Descriptions

Microbot Medical NASDAQ:MBOT

$1.45 0.00 (0.00%)

Closing price 09/14/2026 04:00 PM Eastern

Extended Trading

$1.46 +0.01 (+0.97%)

As of 04:17 AM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Orthofix Medical NASDAQ:OFIX

$9.11 +0.18 (+2.02%)

Closing price 09/14/2026 04:00 PM Eastern

Extended Trading

$9.11 +0.00 (+0.04%)

As of 04:15 AM Eastern

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Avita Medical NASDAQ:RCEL

$10.19 +0.31 (+3.14%)

Closing price 09/14/2026 04:00 PM Eastern

Extended Trading

$10.17 -0.02 (-0.21%)

As of 09/14/2026 07:55 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Treace Medical Concepts NASDAQ:TMCI

$4.63 +0.12 (+2.66%)

Closing price 09/14/2026 04:00 PM Eastern

Extended Trading

$4.75 +0.12 (+2.59%)

As of 09/14/2026 07:44 PM Eastern

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MBOT, OFIX, RCEL, and TMCI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MBOT, OFIX, RCEL, and TMCI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MBOT, OFIX, RCEL, and TMCI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT, OFIX, RCEL, and TMCI Company Descriptions

Microbot Medical NASDAQ:MBOT

Orthofix Medical NASDAQ:OFIX

Avita Medical NASDAQ:RCEL

Treace Medical Concepts NASDAQ:TMCI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MBOT, OFIX, RCEL, and TMCI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MBOT, OFIX, RCEL, and TMCI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MBOT, OFIX, RCEL, and TMCI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT, OFIX, RCEL, and TMCI Company Descriptions

Microbot Medical NASDAQ:MBOT

Orthofix Medical NASDAQ:OFIX

Avita Medical NASDAQ:RCEL

Treace Medical Concepts NASDAQ:TMCI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools